STPH.CN Steep Hill Inc CNQ C$0.055 16 Feb 2026: Oversold bounce setup

STPH.CN stock is trading at C$0.055 on the CNQ on 16 Feb 2026, putting Steep Hill Inc. in an oversold bounce setup ahead of short-term technical tests. Volume is elevated at 46,667 versus an average of 19,107, giving the move traction. Meyka AI, an AI-powered market analysis platform, flags a possible short-term rebound while highlighting valuation and liquidity risks for small-cap cannabis testing plays.

STPH.CN stock technicals and oversold setup

The immediate price is C$0.055, unchanged on the session with a 50-day average of C$0.06 and 200-day average of C$0.06. Volume today is 46,667, or 2.44× average volume, which fits an oversold bounce pattern.

Momentum indicators are thin or unavailable, but the gap between current price and the 50-day average shows short-term oversold pressure. Traders should watch whether volume sustains or fades on a retest above C$0.06.

Fundamentals and valuation for Steep Hill Inc on CNQ

Steep Hill Inc (STPH.CN) has a market cap of C$889,235.00 and 16,167,900 shares outstanding. Reported EPS is -C$0.01 and reported PE reads -5.50, reflecting recent losses and low float.

Balance-sheet metrics are mixed. Cash per share is C$0.13 and book value per share is C$0.12, giving a price-to-book near 0.46. Current ratio is 12.80, indicating liquidity, but free cash flow per share is negative at -C$0.01.

Meyka AI rates STPH.CN with a score out of 100 and forecast

Meyka AI rates STPH.CN with a score out of 100: 71.65 / B+ (BUY). This grade factors in S&P 500 comparison, sector and industry peers, financial growth, key metrics, forecasts, and analyst signals.

Meyka AI’s forecast model projects a near-term target of C$0.07. Compared with the current C$0.055, that implies an upside of 27.27%. A longer-horizon projection of C$0.09331 implies 69.66% upside. Forecasts are model-based projections and not guarantees.

Catalysts, risks and Healthcare sector context

Catalysts include higher-than-average volume, regulatory clarity in cannabis testing, and contract wins for lab services. Steep Hill’s lab services remain relevant to producers needing compliance testing.

Risks include low market cap, limited float, and weak recent earnings. The Healthcare sector is under pressure, down 6.24% on the day, which can amplify downside for small names in Drug Manufacturers – Specialty & Generic. Operational scale is small with 6 full-time employees, raising execution risk.

STPH.CN stock trading plan for an oversold bounce

A tactical oversold-bounce plan: consider a scaled entry near C$0.055 with a tight stop-loss below C$0.040. Set an initial profit target at C$0.07 and a secondary target near C$0.09 if momentum continues.

Keep position sizes small. Low liquidity and wide bid-ask spreads can mean quick moves. Use sell rules if volume falls or price closes back below the entry with rising selling pressure.

Recent performance, liquidity and technical watch points

Year range is C$0.015 to C$0.105, and year-to-date performance shows large percentage swings. Average volume is 19,107, so today’s 46,667 shows short-term interest.

Key levels: support near C$0.015–C$0.040, resistance at C$0.06 and the recent high C$0.105. Watch 50-day and 200-day averages at roughly C$0.06 for confirmation of a sustained bounce.

Final Thoughts

STPH.CN stock trades at C$0.055 on the CNQ in Canada and fits a classic oversold-bounce profile: price sits below the 50-day average while volume is elevated. Short-term traders can target C$0.07 as an initial objective, which aligns with Meyka AI’s model projection and implies 27.27% upside from the current price. A tighter stop below C$0.040 limits downside on the trade. Meyka AI grades the stock 71.65 / B+ (BUY) based on benchmark, sector, growth, and metrics, but the small market cap (C$889,235.00) and low float increase execution risk. Use strict risk management, keep positions small, and watch whether the Healthcare sector’s weakness continues. Forecasts are model-based projections and not guarantees, and this note does not constitute investment advice. For company details see the official site and quote sources below.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.